These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 33259333)

  • 1. Intra-tumoral heterogeneity and immune responses predicts prognosis of gastric cancer.
    Feng W; Wang Y; Chen S; Zhu X
    Aging (Albany NY); 2020 Nov; 12(23):24333-24344. PubMed ID: 33259333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor mutation burden as a biomarker in resected gastric cancer via its association with immune infiltration and hypoxia.
    Wang D; Wang N; Li X; Chen X; Shen B; Zhu D; Zhu L; Xu Y; Yu Y; Shu Y
    Gastric Cancer; 2021 Jul; 24(4):823-834. PubMed ID: 33687617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive analysis of a 14 immune-related gene pair signature to predict the prognosis and immune features of gastric cancer.
    Liu C; Chen B; Huang Z; Hu C; Jiang L; Zhao C
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107074. PubMed ID: 33049494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and molecular relevance of mutant-allele tumor heterogeneity in breast cancer.
    Ma D; Jiang YZ; Liu XY; Liu YR; Shao ZM
    Breast Cancer Res Treat; 2017 Feb; 162(1):39-48. PubMed ID: 28093659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of sex-biased ATRX mutation in female gastric cancer patients with enhanced immunotherapy-related anticancer immunity.
    Ge Y; Wei F; Du G; Fei G; Li W; Li X; Chu J; Wei P
    BMC Cancer; 2021 Mar; 21(1):240. PubMed ID: 33678158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Hub Genes in Gastric Cancer with High Heterogeneity Based on Weighted Gene Co-Expression Network.
    Dong Z; Pei S; Zhao Y; Guo S; Wang Y
    Crit Rev Eukaryot Gene Expr; 2020; 30(2):101-109. PubMed ID: 32558489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytolytic activity score as a biomarker for antitumor immunity and clinical outcome in patients with gastric cancer.
    Hu Q; Nonaka K; Wakiyama H; Miyashita Y; Fujimoto Y; Jogo T; Hokonohara K; Nakanishi R; Hisamatsu Y; Ando K; Kimura Y; Masuda T; Oki E; Mimori K; Oda Y; Mori M
    Cancer Med; 2021 May; 10(9):3129-3138. PubMed ID: 33769705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of Exosome-Related Gene Risk Model to Evaluate the Tumor Immune Microenvironment and Predict Prognosis in Triple-Negative Breast Cancer.
    Qiu P; Guo Q; Yao Q; Chen J; Lin J
    Front Immunol; 2021; 12():736030. PubMed ID: 34659224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive test for chemotherapy response in resectable gastric cancer: a multi-cohort, retrospective analysis.
    Cheong JH; Yang HK; Kim H; Kim WH; Kim YW; Kook MC; Park YK; Kim HH; Lee HS; Lee KH; Gu MJ; Kim HY; Lee J; Choi SH; Hong S; Kim JW; Choi YY; Hyung WJ; Jang E; Kim H; Huh YM; Noh SH
    Lancet Oncol; 2018 May; 19(5):629-638. PubMed ID: 29567071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratumoral heterogeneity contributes to the chemotherapy prognosis of breast cancer.
    Li Y; Wang M; Yang S; Kuang L; Tao X; Yang J; Zhao W; Zhang J
    J Cancer Res Ther; 2022 Sep; 18(5):1268-1275. PubMed ID: 36204872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic analysis and clinical implications of immune cell infiltration in gastric cancer.
    Wu M; Wang Y; Liu H; Song J; Ding J
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32338286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated Analysis Construct a Tumor-Associated Macrophage Novel Signature with Promising Implications in Predicting the Prognosis and Immunotherapeutic Response of Gastric Cancer Patients.
    Xin H; Chen Y; Niu H; Li X; Gai X; Cui G
    Dig Dis Sci; 2024 Jun; 69(6):2055-2073. PubMed ID: 38573378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Signature-Based Classification of Gastric Cancer That Stratifies Tumor Immunity and Predicts Responses to PD-1 Inhibitors.
    Li S; Gao J; Xu Q; Zhang X; Huang M; Dai X; Huang K; Liu L
    Front Immunol; 2021; 12():693314. PubMed ID: 34177954
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Xiao Y; Zhang H; Du G; Meng X; Wu T; Zhou Q; Wang Y; Tan B
    Technol Cancer Res Treat; 2020; 19():1533033820970684. PubMed ID: 33176601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Dynamic Transcriptome Map of Different Tissue Microenvironment Cells Identified During Gastric Cancer Development Using Single-Cell RNA Sequencing.
    Yin H; Guo R; Zhang H; Liu S; Gong Y; Yuan Y
    Front Immunol; 2021; 12():728169. PubMed ID: 34745098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Influence of Immune Heterogeneity on the Effectiveness of Immune Checkpoint Inhibitors in Multifocal Hepatocellular Carcinomas.
    Huang M; He M; Guo Y; Li H; Shen S; Xie Y; Li X; Xiao H; Fang L; Li D; Peng B; Liang L; Yu J; Kuang M; Xu L; Peng S
    Clin Cancer Res; 2020 Sep; 26(18):4947-4957. PubMed ID: 32527942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Key Genes Associated with Prognosis and Tumor Infiltrating Immune Cells in Gastric Cancer Patients Identified by Cross-Database Analysis.
    Zhang T; Wang BF; Wang XY; Xiang L; Zheng P; Li HY; Tao PX; Wang DF; Gu BH; Chen H
    Cancer Biother Radiopharm; 2020 Nov; 35(9):696-710. PubMed ID: 32401038
    [No Abstract]   [Full Text] [Related]  

  • 18. Molecular classification reveals the diverse genetic and prognostic features of gastric cancer: A multi-omics consensus ensemble clustering.
    Hu X; Wang Z; Wang Q; Chen K; Han Q; Bai S; Du J; Chen W
    Biomed Pharmacother; 2021 Dec; 144():112222. PubMed ID: 34607103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastric cancer immune microenvironment score predicts neoadjuvant chemotherapy efficacy and prognosis.
    Zhao S; Liu Y; Ding L; Zhang C; Ye J; Sun K; Song W; Cai S; He Y; Peng J; Xu J
    J Pathol Clin Res; 2024 May; 10(3):e12378. PubMed ID: 38778559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CMA1 is potent prognostic marker and associates with immune infiltration in gastric cancer.
    Shi S; Ye S; Mao J; Ru Y; Lu Y; Wu X; Xu M; Zhu T; Wang Y; Chen Y; Tang X; Xi Y
    Autoimmunity; 2020 Jun; 53(4):210-217. PubMed ID: 32129682
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.